Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy.

Brichkina, Anna; Suezov, Roman; Huber, Magdalena

Brichkina, Anna; Suezov, Roman; Huber, Magdalena.

Afiliación

Brichkina A; Institute of Systems Immunology, Member of the German Center for Lung Research (DZL), Philipps University of Marburg, 35043, Marburg, Germany. anna.brichkina@staff.uni-marburg.de.
Suezov R; Institute of Systems Immunology, Member of the German Center for Lung Research (DZL), Philipps University of Marburg, 35043, Marburg, Germany.
Huber M; Institute of Systems Immunology, Member of the German Center for Lung Research (DZL), Philipps University of Marburg, 35043, Marburg, Germany. magdalena.huber@staff.uni-marburg.de.

Signal Transduct Target Ther ; 8(1): 448, 2023 12 11.

Article en En | MEDLINE | ID: mdl-38072988

Asunto(s)

Metiltransferasas

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Metiltransferasas Idioma: En Revista: Signal Transduct Target Ther Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google